Skip to content
MedsAcross

Medicine

Venlafaxine 37.5 mg extended-release capsule

Venlafaxine · Oral
Available on requestPrescription onlyUS FDAGeneric name

Venlafaxine 37.5 mg extended-release capsule is a generic prescription medicine for oral use, made by 31 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at controlled room temperature, 20°C to 25°C (68° to 77°F)

Key facts

Active ingredient (INN)
Venlafaxine
Brand
Sold under the generic name
Strength
37.5 mg
Dosage form
Extended-release capsule
Route
Oral
Packs
30 capsules, 1000 capsules, 90 capsules and 148 more
Manufacturers
Zydus LifesciencesIndiaAlembic PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaAnnora PharmaIndiaAurobindo PharmaIndia31 labelers on the register
Origin register
US FDA, United States
Storage
Store at controlled room temperature, 20°C to 25°C (68° to 77°F)
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N06AX16 Venlafaxine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 July 2010
Identifiers
RxCUI 313581, 313583, 313585 +1DailyMed set ID e901e476-58bd-4204-baaa-a4634ae65ab3, cb4c04a6-47d1-44ff-8d58-718102fa08eb, 9a30e1b5-272b-4109-ad6c-a3c9a895822f +37NDC 71785-1006, 82009-056, 0093-7384 +37Application ANDA212277, ANDA200834, ANDA076565 +8

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 31 labelers. The register lists 151 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
30 capsule, extended release in 1 bottle65841-751-06Zydus LifesciencesIndia1 June 2011
1000 capsule, extended release in 1 bottle65841-751-10Zydus LifesciencesIndia1 June 2011
90 capsule, extended release in 1 bottle65841-751-16Zydus LifesciencesIndia1 June 2011
30 capsule, extended release in 1 bottle68382-034-06Zydus LifesciencesIndia1 June 2011
1000 capsule, extended release in 1 bottle68382-034-10Zydus LifesciencesIndia1 June 2011
90 capsule, extended release in 1 bottle68382-034-16Zydus LifesciencesIndia1 June 2011
1000 capsule, extended release in 1 bottle70710-1698-0Zydus LifesciencesIndia18 May 2023
30 capsule, extended release in 1 bottle70710-1698-3Zydus LifesciencesIndia18 May 2023
10 blister pack in 1 carton / 10 capsule, extended release in 1 blister pack70710-1698-4Zydus LifesciencesIndia18 May 2023
500 capsule, extended release in 1 bottle70710-1698-5Zydus LifesciencesIndia18 May 2023
90 capsule, extended release in 1 bottle70710-1698-9Zydus LifesciencesIndia18 May 2023
1000 capsule, extended release in 1 bottle70771-1836-0Zydus LifesciencesIndia18 May 2023
30 capsule, extended release in 1 bottle70771-1836-3Zydus LifesciencesIndia18 May 2023
10 blister pack in 1 carton / 10 capsule, extended release in 1 blister pack70771-1836-4Zydus LifesciencesIndia18 May 2023
500 capsule, extended release in 1 bottle70771-1836-5Zydus LifesciencesIndia18 May 2023
90 capsule, extended release in 1 bottle70771-1836-9Zydus LifesciencesIndia18 May 2023
30 capsule, extended release in 1 bottle46708-792-30Alembic PharmaceuticalsIndia10 June 2024
100 capsule, extended release in 1 bottle46708-792-31Alembic PharmaceuticalsIndia10 June 2024
500 capsule, extended release in 1 bottle46708-792-71Alembic PharmaceuticalsIndia10 June 2024
90 capsule, extended release in 1 bottle46708-792-90Alembic PharmaceuticalsIndia10 June 2024
1000 capsule, extended release in 1 bottle46708-792-91Alembic PharmaceuticalsIndia10 June 2024
30 capsule, extended release in 1 bottle62332-792-30Alembic PharmaceuticalsIndia10 June 2024
100 capsule, extended release in 1 bottle62332-792-31Alembic PharmaceuticalsIndia10 June 2024
500 capsule, extended release in 1 bottle62332-792-71Alembic PharmaceuticalsIndia10 June 2024
90 capsule, extended release in 1 bottle62332-792-90Alembic PharmaceuticalsIndia10 June 2024
1000 capsule, extended release in 1 bottle62332-792-91Alembic PharmaceuticalsIndia10 June 2024
1000 capsule, extended release in 1 bottle43598-999-10Dr. Reddy's LaboratoriesIndia9 September 2024
30 capsule, extended release in 1 bottle43598-999-30Dr. Reddy's LaboratoriesIndia9 September 2024
90 capsule, extended release in 1 bottle43598-999-90Dr. Reddy's LaboratoriesIndia9 September 2024
100 capsule, extended release in 1 bottle55111-453-01Dr. Reddy's LaboratoriesIndia1 June 2011
500 capsule, extended release in 1 bottle55111-453-05Dr. Reddy's LaboratoriesIndia1 June 2011
30 capsule, extended release in 1 bottle55111-453-30Dr. Reddy's LaboratoriesIndia1 June 2011
60 capsule, extended release in 1 bottle55111-453-60Dr. Reddy's LaboratoriesIndia1 June 2011
10 blister pack in 1 carton / 10 capsule, extended release in 1 blister pack55111-453-78Dr. Reddy's LaboratoriesIndia1 June 2011
90 capsule, extended release in 1 bottle55111-453-90Dr. Reddy's LaboratoriesIndia1 June 2011
30 capsule, extended release in 1 bottle71785-1006-0Annora PharmaIndia8 July 2019
90 capsule, extended release in 1 bottle71785-1006-1Annora PharmaIndia8 July 2019
500 capsule, extended release in 1 bottle71785-1006-2Annora PharmaIndia8 July 2019
10 blister pack in 1 carton / 10 capsule, extended release in 1 blister pack71785-1006-3Annora PharmaIndia8 July 2019
100 capsule, extended release in 1 bottle65862-527-01Aurobindo PharmaIndia1 June 2011

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 28 December 1993Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Venlafaxine 37.5 mg extended-release capsule.

Compare 1

Other strengths and forms of Venlafaxine

Clinical summary

Venlafaxine is a serotonin and norepinephrine reuptake inhibitor indicated in adults for the treatment of major Depressive Disorder (MDD), among other approved uses. It is available as extended-release capsules, tablets and extended-release tablets for oral use. MedsAcross supplies Venlafaxine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Venlafaxine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Venlafaxine 37.5 mg extended-release capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.